Imbria Pharmaceuticals
![Imbria's Ninerafaxstat Shows Safety Success in Phase 2 Heart Failure Study](https://pharmtales.com/wp-content/uploads/2023/11/Imbria-Pharmaceuticals-Clears-Safety-Hurdles-in-Phase-2-Heart-Failure-Trial-Paving-the-Way-for-Promising-Late-Stage-Development.jpg)
Imbria Pharmaceuticals Clears Safety Hurdles in Phase 2 Heart Failure Trial, Paving the Way for Promising Late-Stage Development
Anika Sharma
Imbria Pharmaceuticals has achieved positive results in a phase 2 trial for its heart failure medication. The Boston-based biotech, in ...